A procurement head at a 400-bed hospital group in East Africa received two quotes for their annual 3-million-syringe tender: one from a regional distributor at USD 0.055 per unit, and one directly from a disposable syringes exporter from India at USD 0.034 FOB Nhava Sheva. The specs were identical — 3-part Luer-lock, EO-sterilised, CE marked. The difference was simply the number of hands the order passed through before it reached her warehouse. Cutting the middleman out of a commodity medical consumable is not a procurement risk — it is a procurement mandate.
Hospitals and distributors importing disposable syringes from Europe or China pay 25–40% more than the factory-direct FOB price available from certified Indian manufacturers — with identical CE marking, ISO 13485 QMS, and full CDSCO export documentation on every order.
India produces an estimated 8–10 billion disposable syringes annually, accounting for roughly 35–40% of global output. The manufacturing belt runs through Surat (Gujarat), Baddi (Himachal Pradesh), and Haridwar (Uttarakhand) — industrial clusters built specifically around medical consumables, with bonded warehousing, a deep raw-material supply chain (medical-grade PP resin, steel needles, EO sterilisation facilities), and freight access via Nhava Sheva, Mundra, and JNPT. Every credible disposable syringes exporter from India in these clusters operates under a CDSCO manufacturing licence, ISO 13485 quality management certification, and CE marking for export markets. The price advantage is structural, not a race to the bottom: Indian PP resin costs, moulding labour, and sterilisation overhead are 40–55% lower than equivalent European inputs, and the savings flow through to the FOB price without compromising on the quality management system.
For a government health ministry or hospital group running 500,000+ syringes per month, this matters. At USD 0.034–0.042 FOB India versus USD 0.055–0.075 from a European or regional distributor, a 2-million-unit annual contract saves USD 40,000–80,000 — enough to fund a ward upgrade or three months of nursing overtime. What does it take to actually capture that saving? Direct sourcing from a verified Indian manufacturer with the right export certification stack.
A public health procurement authority in West Africa consolidated its syringe supply to a single Indian factory-direct exporter and reduced its per-unit landed cost by 38% over two annual tender cycles — while raising its quality hold rate from 94% to 99.1% on incoming inspection.
2-part and 3-part Luer-lock and Luer-slip, 1–50 mL, CE marked, ISO 13485. Disposable syringes · Full catalogue · Request quote · WhatsApp +91 84601 91818 · info@manshavimpex.com
| Factor | Detail |
|---|---|
| Products | 2-part (Luer-slip and Luer-lock) and 3-part (Luer-lock with rubber stopper) disposable syringes — 1 mL, 2 mL, 3 mL, 5 mL, 10 mL, 20 mL, 50 mL |
| Standards | ISO 7886-1 (sterile hypodermic syringes for single use), EN ISO 80369-7 (Luer fittings) |
| Certifications | ISO 13485, CE marking, WHO-GMP compliant manufacturing practices |
| Sterilisation | Ethylene oxide (EO), validated per ISO 11135; sterility assurance level SAL 10⁻⁶ |
| HS Code | 9018.31.00 (hypodermic syringes, with or without needles) — confirm with destination customs authority |
| MOQ (export) | 1×20ft FCL (~2–4 million units depending on size mix); pilot orders from 200,000 units negotiable |
| Lead time | 3–4 weeks FOB Nhava Sheva or Mundra after PO and L/C confirmation |
| Documentation | CE DoC, ISO 13485 certificate, CDSCO CFS, CoA per lot, packing list, COO, health certificate on request |
| Incoterms | FOB / CIF / CFR; DDP available for select markets |
The most common source of confusion in syringe procurement specs is the 2-part versus 3-part distinction. A 2-part syringe (barrel + plunger rod, no rubber stopper) is cheaper to manufacture, lighter to ship, and adequate for vaccine programmes and low-viscosity injections. A 3-part syringe adds a rubber stopper on the plunger — the additional gasket dramatically reduces back-pressure and leakage risk for viscous drugs, insulin, and precise aspiration. Most institutional tenders in Africa and Asia specify 3-part Luer-lock for general ward use, because the rubber stopper gives nurses a more consistent feel during injection and aspiration. 2-part Luer-slip syringes are preferred for mass vaccination campaigns and immunisation programmes (UNICEF/GAVI supply chains), where unit cost and volume are paramount.
Manshav Impex exports both configurations. For a first purchase, the rule is simple: if your end user is a hospital ward or surgery suite, quote 3-part Luer-lock. If the end user is a vaccination programme or primary health centre running on a public-sector tender, quote 2-part Luer-slip unless the tender spec says otherwise. Mixing both in one container is possible — we accommodate mixed-size FCLs on a minimum 200,000 units per line item basis.
| Size | Type | FOB India (USD/unit) | Units per 20ft FCL (approx) | FCL Value (USD approx) |
|---|---|---|---|---|
| 1 mL | 3-part Luer-lock | 0.036–0.042 | 3,500,000–4,000,000 | 126,000–168,000 |
| 2 mL | 3-part Luer-lock | 0.034–0.040 | 3,000,000–3,500,000 | 102,000–140,000 |
| 5 mL | 3-part Luer-lock | 0.038–0.044 | 2,200,000–2,500,000 | 83,600–110,000 |
| 10 mL | 3-part Luer-lock | 0.042–0.050 | 1,400,000–1,600,000 | 58,800–80,000 |
| 20 mL | 3-part Luer-lock | 0.052–0.062 | 800,000–1,000,000 | 41,600–62,000 |
| 50 mL | 3-part Luer-lock | 0.075–0.090 | 400,000–500,000 | 30,000–45,000 |
| 1 mL (insulin) | 2-part Luer-slip | 0.028–0.034 | 4,500,000–5,000,000 | 126,000–170,000 |
Landed cost on top of FOB India typically adds 8–14% for sea freight (Nhava Sheva to Mombasa, Lagos, or Accra) plus destination import duty and clearance. For most African and Asian markets, the all-in landed cost for a 5 mL 3-part syringe from India runs USD 0.044–0.054 per unit — still 20–35% below what a distributor in Dubai, Singapore, or Brussels charges for equivalent CE-marked product. Is there a quality catch? There isn't one — the CE mark and ISO 13485 certificate are the same regulatory floor as any European brand. The price difference is factory location, not factory standard.
The document stack for a syringe consignment is standard across most importing markets and Manshav prepares every line item as part of the shipping package: commercial invoice and packing list, bill of lading or airway bill, Certificate of Origin (COO from FIEO or Chamber of Commerce), CDSCO Certificate of Free Sale (CFS) showing the product is licensed for manufacture and sale in India, CE Declaration of Conformity (DoC) issued by the manufacturer, ISO 13485 certificate from the accredited certification body, Certificate of Analysis (CoA) for each production lot, and a product labelling sample for customs review.
For markets with their own medical device registration requirements — NAFDAC (Nigeria), KEBS/PPB (Kenya), Ghana FDA, EFDA (Ethiopia), EDA (Egypt) — the CDSCO CFS and CE DoC are the foundation documents for the local registration dossier. Manshav provides these as standard on every order; if your market requires an apostille or consular attestation, flag it when requesting a quote and we factor the processing time (typically 10–15 additional working days) into the shipment schedule.
Most government and NGO tender specs for disposable syringes reference ISO 7886-1, CE marking or equivalent national standard, and a minimum two-year shelf life. Indian-manufactured syringes from a CDSCO-licenced facility meet all three out of the box. The typical tender evaluation question is not quality — it's documentation completeness. Tenders that reject Indian bids almost always do so because the bid pack was missing a legible ISO 13485 certificate, a CoA for a specific size, or a valid CFS with the correct product description. None of these are production problems; they are paperwork problems that a disciplined exporter eliminates at quote stage.
For large tenders above 5 million units, buyers sometimes ask for a pre-shipment inspection (PSI) by a third-party inspector at the Indian factory — SGS, Bureau Veritas, Intertek, or similar. Manshav accommodates PSI at our Surat facility with one week's notice; the inspection fee is the buyer's cost, but the factory time, documentation access, and sample submission are provided without charge. If you've lost a tender before because your Indian supplier couldn't produce the inspector on time, that gap won't happen here.
Manshav Impex exports disposable syringes from a minimum of 200,000 units per size for pilot orders, scaling to full 20ft FCL loads of 2–4 million units for regular supply. Mixed-size FCLs are available from 200,000 units per line item.
Yes. Manshav Impex syringes carry CE marking (Declaration of Conformity under EU MDD/MDR) and are manufactured under an ISO 13485-certified quality management system. Both certificates are provided with every order.
FOB Nhava Sheva pricing ranges from USD 0.028–0.034 per unit for 1 mL 2-part Luer-slip syringes to USD 0.075–0.090 for 50 mL 3-part Luer-lock syringes, depending on size and order volume. Request a formal quotation for your specific size mix and quantity.
Standard documentation includes: commercial invoice and packing list, bill of lading, Certificate of Origin (FIEO/Chamber), CDSCO Certificate of Free Sale, CE Declaration of Conformity, ISO 13485 certificate, and Certificate of Analysis per production lot. Apostille or consular attestation is available on request with additional lead time.
Yes. For markets requiring local device registration (NAFDAC, Ghana FDA, PPB Kenya, EDA Egypt, EFDA Ethiopia, and others), Manshav provides the full manufacturer-side dossier — CE DoC, ISO 13485, CDSCO CFS, CoA, and product labelling — as standard with every quote. Apostilled documentation for consular submission is available on request.
Indian IV cannula exporters ship DEHP-free, ISO 10555-1-compliant peripheral IV catheters in gauges 14G–26G at FOB USD 0.04–0.11 per unit — 55–75% below EU brand landed cost. MOQ 20,000 units per gauge, 14–21 days lead time, full CE and ISO 13485 documentation.
Ansell and Mölnlycke make excellent surgical gloves — but distributor pricing runs 4–8× a CE-marked, EN 455-compliant Indian source. Manshav Impex exports sterile latex and nitrile surgical gloves at FOB USD 0.09–0.22/pair with CE DoC, CFS, and lot traceability.
A practical guide for Nigerian hospital buyers and distributors importing disposable surgical gowns from India. Covers NAFDAC CRIA registration, AAMI barrier levels, FOB pricing, container math, and how to vet factory direct vs. trading agents.